Westchester Capital Management (New York) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$104M |
| 2 |
SGFY
Signify Health, Inc.
SGFY
|
+$49.6M |
| 3 |
SJR
Shaw Communications Inc.
SJR
|
+$48.3M |
| 4 |
ATCO
Atlas Corp.
ATCO
|
+$47.8M |
| 5 |
AUY
Yamana Gold, Inc.
AUY
|
+$43.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$143M |
| 2 |
AVLR
Avalara, Inc.
AVLR
|
+$103M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$96.2M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$93.6M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 41.42% |
| 2 | Technology | 12.77% |
| 3 | Healthcare | 11.09% |
| 4 | Industrials | 10.67% |
| 5 | Energy | 4.51% |
Similar funds
Westchester Capital Management (New York)'s Q4 2022 Portfolio in Review
As of Q4 2022, Westchester Capital Management (New York) held 629 positions worth $3.64B, up 2.4% from $3.55B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Westchester Capital Management (New York)'s Q4 2022 filing shows 150 new, 117 increased, 17 reduced and 182 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $143M.
By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.
- Westchester Capital Management (New York)'s largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M.
- Westchester Capital Management (New York) added most to Signify Health, Inc. in Q4 2022, an estimated $49.6M increase.
- Westchester Capital Management (New York)'s biggest Q4 2022 reduction was Silicon Motion, cutting an estimated $61.4M.
- Westchester Capital Management (New York) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $143M.
- Westchester Capital Management (New York)'s ten largest holdings make up 32% of its $3.64B portfolio in Q4 2022.
- Westchester Capital Management (New York) opened 150 new positions and closed 182 in Q4 2022.
- Westchester Capital Management (New York)'s portfolio value rose 2.4% quarter-over-quarter to $3.64B.
Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.